Judith A Shizuru
Affiliations: | Medicine | Stanford University School of Medicine, Palo Alto, CA, United States |
Website:
https://biox.stanford.edu/people/judith-shizuruGoogle:
"Judith Anne Shizuru" OR "Judith A Shizuru"Bio:
https://med.stanford.edu/bmt/research/shizuru-lab.html
https://www.ludwigcancerresearch.org/wp-content/uploads/2017/08/THE-TRANSPLANT-SORCERER_1.pdf
https://books.google.com/books?id=PJ0vAQAAIAAJ
Parents
Sign in to add mentorC. Garrison Fathman | grad student | 1986 | Stanford | |
(Transplantation of pancreatic islets across major histocompatibility barriers) | ||||
Ronald C Merrell | grad student | 1986 | Stanford | |
Irving L. Weissman | post-doc | Stanford Medical School | ||
(Collaborator/Fathman Post-doc) |
Children
Sign in to add traineeCasey Burnett | research assistant | Stanford Medical School | |
Steve Jungers | research assistant | Stanford Medical School | |
Alan Le | research assistant | Stanford Medical School | |
Jessica Poyser | research assistant | 2010- | Stanford Medical School |
Anne Le | research assistant | 2016- | Stanford Medical School |
Peter Tran | grad student | 2018- | Stanford Medical School |
Brenda Velasco | grad student | 2018- | Stanford Medical School |
Akanksha Chhabra | post-doc | Stanford Medical School (Cell Biology Tree) | |
Andriyana K Bankova | post-doc | 2018- | Stanford Medical School |
Hye-Sook Kwon | research scientist | 2012- | Stanford Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bader CS, Pavlova A, Lowsky R, et al. (2023) Single Center Randomized Trial of T-reg graft alone versus T-reg graft Plus Tacrolimus for the Prevention of Acute GVHD. Blood Advances |
Magnani CF, Myburgh R, Brunn S, et al. (2023) Erratum: Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells. Molecular Therapy Oncolytics. 30: 150 |
Magnani CF, Myburgh R, Brunn S, et al. (2023) Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells. Molecular Therapy Oncolytics. 30: 56-71 |
Chang CA, Bhagchandani P, Poyser J, et al. (2022) Curative islet and hematopoietic cell transplantation in diabetic mice without toxic bone marrow conditioning. Cell Reports. 41: 111615 |
Liang EC, Craig J, Torelli S, et al. (2022) Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern Era. Transplantation and Cellular Therapy |
Bankova AK, Caveney J, Yao B, et al. (2022) Real-world Experience of Cryopreserved Allogeneic Hematopoietic Grafts in the COVID-19 Pandemic: A Single Center Report. Transplantation and Cellular Therapy |
Bankova AK, Pang W, Velasco BJ, et al. (2021) 5-Azacytidine depletes hematopoietic stem cells and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice. Blood Advances |
Jensen KP, Hongo D, Ji X, et al. (2021) Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients. Blood Advances |
Muffly L, Sundaram V, Chen C, et al. (2021) Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia. Blood Advances. 5: 3147-3151 |
Spiegel JY, Patel S, Muffly L, et al. (2021) CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nature Medicine |